Should You Sell Mereo BioPharma Group plc - ADR (MREO) Stock Wednesday Morning?

Mereo BioPharma Group plc - ADR (MREO) is down -2.79%% today.

MREO has an Overall Score of 91. Find out what this means to you and get the rest of the rankings on MREO!

MREO stock closed at $1.79 and is down -$0.05 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. MREO has a strong overall score of 91 meaning the stock holds a better value than 91% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock. MREO gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral. Mereo BioPharma Group plc - ADR currently has the 135th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders. Mereo BioPharma Group plc - ADR's Overall and Short-Term Technical score paint a strong picture for MREO's recent trading patterns and forecasted price. Click Here To Get The Full Report on Mereo BioPharma Group plc - ADR (MREO)